## MOH: Molina Healthcare Inc - XLV: Healthcare

### Executive Summary

PARABOLIC warning: MRS_20 at 11.2% exceeds exhaustion threshold (10.0%). Extreme momentum typically precedes mean reversion. Consider profit-taking or tight stops.

- **Horizon:** 1-5 days (momentum)
- **Risk Profile:** High - extreme momentum reversal risk
- **Stop Type:** Fixed 2xATR ($155.20)
- **If Wrong:** Exit on momentum reversal or stop hit
- **Invalidation:** MRS_20 drops below exhaustion threshold

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 2, Bearish: 0)

**1. Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Molina Healthcare, Inc. (MOH) and Encourages Stockholders to Learn More About the Investigation**
- Source: WHNT.com | 20251209T160824 | Neutral | Relevance: 99%
-  Bronstein, Gewirtz & Grossman, LLC has launched an investigation into Molina Healthcare, Inc. (MOH) regarding potential corporate wrongdoing involving the company and its officers/directors. The firm is encouraging stockholders who purchased Molina securities before February 5, 2025, and still hold them, to learn more about the investigation and potentially assist. Investors can find additional information or contact the firm to participate, with no direct cost involved as the firm operates on a contingency fee basis.

**2. MOH, Aeroflow Team Up to Offer Virtual Diabetes Care in South Carolina**
- Source: TradingView | 20251211T180841 | Bullish | Relevance: 99%
-  Molina Healthcare of South Carolina (MOH) has partnered with Aeroflow Health to provide virtual nutrition counseling and Diabetes Self-Management Education (DSME) services to its Commercial and Medicare members in South Carolina. This collaboration aims to help members manage blood sugar levels, adopt healthy lifestyles, and reduce diabetes-related complications through personalized virtual support from licensed dietitians and certified diabetes care specialists. The initiative is expected to strengthen Molina Healthcare's presence in South Carolina and attract new members by offering convenient, high-quality virtual care for chronic conditions.

**3. Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Molina Healthcare, Inc. (MOH) and Encourages Stockholders to Learn More About the Investigation**
- Source: WJBF | 20251209T160815 | Neutral | Relevance: 99%
-  Bronstein, Gewirtz & Grossman, LLC has launched an investigation into Molina Healthcare, Inc. (MOH) concerning potential corporate wrongdoing by its officers and/or directors. The firm encourages stockholders who purchased Molina securities prior to February 5, 2025, and still hold them, to contact them for more information and to assist with the investigation. This investigation is being conducted on a contingency fee basis.

**4. Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Molina Healthcare, Inc. (MOH) and Encourages Stockholders to Learn More About the Investigation**
- Source: WREG.com | 20251209T160937 | Neutral | Relevance: 99%
-  Bronstein, Gewirtz & Grossman, LLC has launched an investigation into Molina Healthcare, Inc. (MOH) regarding potential corporate wrongdoing by the company and its officers/directors. The firm is encouraging stockholders who purchased Molina securities before February 5, 2025, and still hold them, to engage with the investigation. Investors can find more information and assist the investigation by visiting the firm's website or contacting their client relations team.

**5. The MolinaCares Accord Commits $200,000 to Fund Maternal Health Navigators in Mississippi**
- Source: Business Wire | 20251209T130246 | Bullish | Relevance: 99%
-  The MolinaCares Accord and Molina Healthcare of Mississippi announced a $200,000 grant to Magnolia Medical Foundation over four years. This funding will support maternal health navigators and operations at Foundation clinics from 2026 to 2028, aiming to expand access to maternal healthcare in Mississippi. The initiative addresses the state's high number of maternity care deserts and promotes critical care for underserved populations.

### Analyst Activity

**Target Signal:** VERY_BEARISH (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-12 | Wells Fargo | $165 | $231 | -29% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-12 | Wells Fargo | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 8 ($0.44M) |
| Sells | 1 ($0.05M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 61.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 11.9% (+0.1%)
- Capital World Invest: 9.5% (-2.0%)
- Blackrock Inc.: 8.4% (-3.9%)
- Price (T.Rowe) Assoc: 6.5% (+58.8%)
- AQR Capital Manageme: 5.4% (+217.0%)

### Key Risks

1. Elevated short interest (11.4%): bears positioning against stock.
2. Long-term trend broken: trading 28.8% below SMA200.
3. Falling knife pattern: rapid decline without stabilization, catch risk elevated.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_20 improving +8.0% over 5 days suggests accumulation.

### Fundamentals

Analyst sentiment negative (1 target cuts vs 0 raises). Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $9.0B |
| Beta | 0.52 |
| 52W Range | $133.40 - $359.97 |
| Short Interest | 11.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | -0.62 |
| Forward P/E | 11.9 |
| Current P/E | 11.8 |
| YoY Growth | -0.8% |
| EPS Direction | FALLING |

### Technicals

MRS_20 strengthening from 3.2% to 11.2% (+8.0% in 5 days), confirming momentum buildup. Extended beyond STRENGTH zone (11.2% > 10.0%), caution on chasing. MRS_5 at 5.4% confirms short-term momentum alignment. AM_20 at 13.6% shows strong absolute momentum above own 20MA. Outperforming sector by 13.5pp, stock-specific strength. Below SMA200 (0.71x), long-term trend not supportive. MACD histogram positive (3.51), confirming momentum.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 11.23% (CS: 96) | Strong |
| RSI_14 | 66.3 | Neutral |
| MACD Histogram | 3.51 | Bullish |
| vs SMA20 | 1.136x | Above |
| vs SMA50 | 1.021x | Above |
| vs SMA200 | 0.712x | Below |

### Decision

- **Verdict:** SELL
- **Thesis:** PARABOLIC

### Trade Setup

- **Entry:** $166.90
- **Stop Loss:** $155.20 (7.0% risk)
- **Target:** $178.60 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** PARABOLIC thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 117
- **Position Value:** $19,527.30
- **Portfolio %:** 19.53%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | IGNITION (Zone D) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-02-04 (Est: $0.64)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $3.89 | $1.84 | -52.7% |
| 2025Q2 | $5.53 | $5.48 | -0.9% |
| 2025Q1 | $5.96 | $6.08 | +2.0% |
| 2024Q4 | $5.88 | $5.05 | -14.1% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*